Scott Howell on the Very Large Costs of Drug Utilization Management
Listen now
Description
Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
More Episodes
Published 03/26/24
Learn more about academic opportunities in Health Policy and Law at UCSF and UC Law San Francisco. Health Affairs' Editor-in-Chief Alan Weil interviews Amanda Chen of Harvard University on her recent paper that identifies major gaps and discrepancies in new CMS nursing home ownership data. From...
Published 03/26/24
Learn more about academic opportunities in Health Policy and Law at UCSF and UC Law San Francisco. Health Affairs' Editor-in-Chief Alan Weil interviews Courtney Baird of Brown University on her recent paper that explores how county-level mandates were generally effective at slowing COVID-19...
Published 03/19/24